161 related articles for article (PubMed ID: 25915825)
1. Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy.
Fujii K; Karpova MB; Asagoe K; Georgiev O; Dummer R; Urosevic-Maiwald M
Leukemia; 2015 Oct; 29(10):2024-32. PubMed ID: 25915825
[TBL] [Abstract][Full Text] [Related]
2. Versican isoform V1 regulates proliferation and migration in high-grade gliomas.
Onken J; Moeckel S; Leukel P; Leidgens V; Baumann F; Bogdahn U; Vollmann-Zwerenz A; Hau P
J Neurooncol; 2014 Oct; 120(1):73-83. PubMed ID: 25064688
[TBL] [Abstract][Full Text] [Related]
3. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
[TBL] [Abstract][Full Text] [Related]
4. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts.
Lee CS; Ungewickell A; Bhaduri A; Qu K; Webster DE; Armstrong R; Weng WK; Aros CJ; Mah A; Chen RO; Lin M; Sundram U; Chang HY; Kretz M; Kim YH; Khavari PA
Blood; 2012 Oct; 120(16):3288-97. PubMed ID: 22936659
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
7. Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting.
Kischel P; Waltregny D; Dumont B; Turtoi A; Greffe Y; Kirsch S; De Pauw E; Castronovo V
Int J Cancer; 2010 Feb; 126(3):640-50. PubMed ID: 19662655
[TBL] [Abstract][Full Text] [Related]
8. Versican V1 isoform regulates cell-associated matrix formation and cell behavior differentially from aggrecan in Swarm rat chondrosarcoma cells.
Wasa J; Nishida Y; Shinomura T; Isogai Z; Futamura N; Urakawa H; Arai E; Kozawa E; Tsukushi S; Ishiguro N
Int J Cancer; 2012 May; 130(10):2271-81. PubMed ID: 21671478
[TBL] [Abstract][Full Text] [Related]
9. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma.
Huang Y; Su MW; Jiang X; Zhou Y
Blood; 2015 Feb; 125(9):1435-43. PubMed ID: 25548321
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.
Singh N; Liu G; Chakrabarty S
Int J Cancer; 2013 May; 132(9):1996-2005. PubMed ID: 23055106
[TBL] [Abstract][Full Text] [Related]
11. Cancer metastasis and EGFR signaling is suppressed by amiodarone-induced versican V2.
Lee HC; Su MY; Lo HC; Wu CC; Hu JR; Lo DM; Chao TY; Tsai HJ; Dai MS
Oncotarget; 2015 Dec; 6(40):42976-87. PubMed ID: 26515726
[TBL] [Abstract][Full Text] [Related]
12. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP
Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612
[TBL] [Abstract][Full Text] [Related]
13. The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2.
Arslan F; Bosserhoff AK; Nickl-Jockschat T; Doerfelt A; Bogdahn U; Hau P
Br J Cancer; 2007 May; 96(10):1560-8. PubMed ID: 17453002
[TBL] [Abstract][Full Text] [Related]
14. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis.
Sheng W; Wang G; Wang Y; Liang J; Wen J; Zheng PS; Wu Y; Lee V; Slingerland J; Dumont D; Yang BB
Mol Biol Cell; 2005 Mar; 16(3):1330-40. PubMed ID: 15635104
[TBL] [Abstract][Full Text] [Related]
15. Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
Du WW; Yang BB; Yang BL; Deng Z; Fang L; Shan SW; Jeyapalan Z; Zhang Y; Seth A; Yee AJ
PLoS One; 2011; 6(11):e26396. PubMed ID: 22096483
[TBL] [Abstract][Full Text] [Related]
16. Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior.
Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Bassols A
Int J Mol Med; 2011 Feb; 27(2):269-75. PubMed ID: 21136024
[TBL] [Abstract][Full Text] [Related]
17. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.
Kharma B; Baba T; Mandai M; Matsumura N; Murphy SK; Kang HS; Yamanoi K; Hamanishi J; Yamaguchi K; Yoshioka Y; Konishi I
Int J Cancer; 2013 Nov; 133(9):2234-44. PubMed ID: 23595697
[TBL] [Abstract][Full Text] [Related]
18. Histone Demethylase LSD1 Inhibitors Prevent Cell Growth by Regulating Gene Expression in Esophageal Squamous Cell Carcinoma Cells.
Hoshino I; Akutsu Y; Murakami K; Akanuma N; Isozaki Y; Maruyama T; Toyozumi T; Matsumoto Y; Suito H; Takahashi M; Sekino N; Komatsu A; Suzuki T; Matsubara H
Ann Surg Oncol; 2016 Jan; 23(1):312-20. PubMed ID: 25791791
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors.
Setoguchi T; Kikuchi H; Yamamoto M; Baba M; Ohta M; Kamiya K; Tanaka T; Baba S; Goto-Inoue N; Setou M; Sasaki T; Mori H; Sugimura H; Konno H
Cancer Sci; 2011 Apr; 102(4):883-9. PubMed ID: 21244575
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
